Sylvester E. Vizi

501 total citations
16 papers, 417 citations indexed

About

Sylvester E. Vizi is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Sylvester E. Vizi has authored 16 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 4 papers in Pharmacology. Recurrent topics in Sylvester E. Vizi's work include Neuroscience and Neuropharmacology Research (5 papers), Ion channel regulation and function (4 papers) and Receptor Mechanisms and Signaling (4 papers). Sylvester E. Vizi is often cited by papers focused on Neuroscience and Neuropharmacology Research (5 papers), Ion channel regulation and function (4 papers) and Receptor Mechanisms and Signaling (4 papers). Sylvester E. Vizi collaborates with scholars based in Hungary, United States and Bulgaria. Sylvester E. Vizi's co-authors include J. Knoll, Beáta Sperlágh, M Impicciatore, G. Bertaccini, Miklós Palkovits, András Z. Rónai, László G. Hársing, Henry Sershen, Ábel Lajtha and A Rakovska and has published in prestigious journals such as Gastroenterology, Biochemical Pharmacology and Life Sciences.

In The Last Decade

Sylvester E. Vizi

14 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvester E. Vizi Hungary 8 266 176 75 57 54 16 417
J. Crist United States 9 248 0.9× 203 1.2× 77 1.0× 115 2.0× 127 2.4× 12 550
M. F. Shuba Ukraine 16 373 1.4× 556 3.2× 62 0.8× 130 2.3× 50 0.9× 67 782
M. Parizon United States 8 158 0.6× 113 0.6× 176 2.3× 52 0.9× 177 3.3× 8 376
M. Raab Germany 13 140 0.5× 94 0.5× 31 0.4× 76 1.3× 130 2.4× 26 410
J.M. Hills United Kingdom 9 262 1.0× 133 0.8× 53 0.7× 114 2.0× 49 0.9× 9 448
D.J. Trezise United Kingdom 11 147 0.6× 194 1.1× 217 2.9× 133 2.3× 139 2.6× 15 436
Leonard E. Parra United States 8 157 0.6× 131 0.7× 86 1.1× 129 2.3× 29 0.5× 8 375
Daniel J. Williford United States 11 161 0.6× 184 1.0× 6 0.1× 81 1.4× 77 1.4× 14 445
Norio Akaike Japan 9 346 1.3× 335 1.9× 78 1.0× 108 1.9× 87 1.6× 13 569
S D Collins United Kingdom 7 160 0.6× 148 0.8× 56 0.7× 262 4.6× 35 0.6× 14 452

Countries citing papers authored by Sylvester E. Vizi

Since Specialization
Citations

This map shows the geographic impact of Sylvester E. Vizi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvester E. Vizi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvester E. Vizi more than expected).

Fields of papers citing papers by Sylvester E. Vizi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvester E. Vizi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvester E. Vizi. The network helps show where Sylvester E. Vizi may publish in the future.

Co-authorship network of co-authors of Sylvester E. Vizi

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvester E. Vizi. A scholar is included among the top collaborators of Sylvester E. Vizi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvester E. Vizi. Sylvester E. Vizi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Rakovska, A, et al.. (2003). Physiological release of striatal acetylcholine (in vivo): effect of somatostatin on dopaminergic–cholinergic interaction. Brain Research Bulletin. 61(5). 529–536. 22 indexed citations
2.
Szántay, Csaba, Lajos Szabó, G. Zsilla, & Sylvester E. Vizi. (2002). Azaberbene Derivatives as α2A-Adrenoceptor Antagonists. Archiv der Pharmazie. 335(1). 22–26.
3.
Haskó, György, Zoltán Németh, Sylvester E. Vizi, Andrew L. Salzman, & C. Ákos Szabó. (1998). STIMULATION OF β-ADRENOCEPTORS INHIBITS ENDOTOXIN-INDUCED IL-12 AND MIP-1α PRODUCTION IN MICE.. Shock. 9(Supplement). 28–29. 1 indexed citations
4.
Németh, Zoltán H., György Haskó, Sylvester E. Vizi, Andrew L. Salzman, & C. Ákos Szabó. (1998). BLOCKADE OF α2-ADRENOCEPTORS INHIBITS ENDOTOXIN-INDUCED IL-12 AND MIP-1α PRODUCTION IN MICE.. Shock. 9(Supplement). 32–32. 1 indexed citations
5.
Haskó, György, Csaba Szabó, Zoltán Németh, & Sylvester E. Vizi. (1997). MODULATION OF CYTOKINE AND NITRIC OXIDE PRODUCTION BY ADRENERGIC, DOPAMINERGIC AND ADENOSINE RECEPTOR LIGANDS IN ENDOTOXEMIA. Shock. 7(Supplement). 27–27. 1 indexed citations
6.
Sperlágh, Beáta & Sylvester E. Vizi. (1996). Neuronal synthesis, storage and release of ATP. Seminars in Neuroscience. 8(4). 175–186. 98 indexed citations
7.
Hársing, László G., Henry Sershen, Sylvester E. Vizi, & Ábel Lajtha. (1992). N-type calcium channels are involved in the dopamine releasing effect of nicotine. Neurochemical Research. 17(7). 729–734. 27 indexed citations
8.
Hársing, László G., György Lónárt, & Sylvester E. Vizi. (1990). Berbanes: search for novel alpha-2 adrenoceptor antagonists.. PubMed. 40(6). 697–708. 5 indexed citations
9.
Vizi, Sylvester E., et al.. (1985). Transient inhibition of the muscarinic actions of carbachol during reactivation of the electrogenic sodium pump in guinea pig taenia caeci smooth muscle. Canadian Journal of Physiology and Pharmacology. 63(6). 663–668.
10.
Rónai, András Z., et al.. (1983). The conversion of met-enkephalin-Arg6, Phe7 to met-enkephalin in rabbit ear artery. Life Sciences. 33. 101–104. 12 indexed citations
11.
Vizi, Sylvester E. & Miklós Palkovits. (1978). Acetylcholine content in different regions of the rat brain. Brain Research Bulletin. 3(2). 93–96. 34 indexed citations
12.
Vizi, Sylvester E., András Z. Rónai, László G. Hársing, & J. Knoll. (1977). Inhibitory effect of dopamine on acetylcholine release from caudate nucleus.. PubMed. 29(3). 201–11. 20 indexed citations
13.
Rónai, András Z. & Sylvester E. Vizi. (1975). The effect of lithium treatment on the acetylcholine content of rat brain. Biochemical Pharmacology. 24(19). 1819–1820. 9 indexed citations
14.
Vizi, Sylvester E.. (1973). Reply of the authors–Polypeptides, Acetylcholine Release, and Gut Motility. Gastroenterology. 65(6). 993–994. 2 indexed citations
15.
Vizi, Sylvester E., G. Bertaccini, M Impicciatore, & J. Knoll. (1973). Evidence that Acetylcholine Released by Gastrin and Related Polypeptides Contributes to their Effect on Gastrointestinal Motility. Gastroenterology. 64(2). 268–277. 184 indexed citations
16.
Vizi, Sylvester E.. (1972). Mechanism of acetylcholine release; presynaptic inhibition by noradrenaline of acetylcholine release in autonomic nervous system.. PubMed. 42(3). 239–48. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026